Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

Annals of Oncology

Volumn 10, Issue 12, 1999, Pages 1461-1465

  Von Der Maase, H ^a   Andersen, L ^a   Crino L ^b   Weinknecht, S ^c   Dogliotti, L ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Ospedale Policlinico   (Italy)

^c Abteilung für Urologie   (Germany)

^d SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Bladder cancer; Gemcitabine cisplatin combination; Phase II study; Transitional cell carcinoma

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; MALE; METASTASIS; MULTICENTER STUDY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR;

EID: 0033390548     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008331111654     Document Type: Article

References (17)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Ca Cancer J Clin 1996; 46: 5-27.
2. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-107.
3. Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-58.
4. Logothetis CJ, Dexus FH, Finn L et al. A prospective, randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol 1990; 8: 1050-5.
5. Loehrer PJ Sr, Einhorn LH, Elson PJ et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A Cooperative Group study. J Clin Oncol 1992; 10: 1066-73.
6. Saxman SB, Propert KJ, Einhorn LH et al. Long-term follow-up of a phase III intergroup study of methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: A Cooperative Group study. J Clin Oneol 1997; 15: 2564-9.
7. Pollera CF, Ceribelli A, Crecco M, Calabresi F. Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study. Ann Oncol 1994; 5: 182-4.
8. Lorusso V, Pollera CF, Antimi M et al. A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Eur J Cancer 1998; 34: 1208-12.
9. Stadler WM, Kuzel T, Roth B et al. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol 1997; 15: 3394-8.
10. Moore MJ, Tannock IF, Scott Ernst D et al. Gemcitabine: A promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol 1997; 15: 3441-5.
11. Crinó L, Scagliotti G, Marangolo M et al. Cisplatin gemcitabine combination in advanced non-small-cell lung cancer: A phase II study. J Clin Oncol 1997; 15: 297-303.
12. Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 1997; 15: 744-9.
13. Antón A, Carrato A, González-Larriba JL et al. Phase II activity of gemcitabine in combination with cisplatin in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1996; 15: 380 (Abstr 1134).
14. Sandler A, Nemunaitis J, Dehnam C et al. Phase III study of cisplalin (C) with or without gemcitabine (G) in patients with advanced non-small-cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1998; 17: 454a (Abstr 1747).
15. World Health Organization. Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48, Geneva: WHO 1979.
16. Stadler W, Carducci M, Raghavan D et al. Gemcitabine (GEM) plus cisplatin (CDDP) in metastatic transitional cell carcinoma (TCC): Final results of a phase II study. Proc Am Soc Clin Oncol 1998; 17: 320a (Abstr 1215).
17. Moore MJ, Tannock I, Winquist E et al. Gemcitabine (G) + cisplatin (C): an active regimen in advanced transitional cell carcinoma (TCC). Proc Am Soc Clin Oncol 1998; 17: 320a (Abstr 1234).